Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new Locations section is added listing study sites in New York, Ohio, and Texas, consolidating location information that was previously shown as separate location entries.
    Difference
    0.5%
    Check dated 2025-12-23T17:16:33.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added; Revision: v3.2.0 removed. These are minor site version updates and do not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:06:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The government funding lapse notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:26:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The new page shows a warning icon/banner and a newer last update date. Core study content such as eligibility criteria, primary outcomes, and intervention details appears unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T12:56:55.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-05T17:35:51.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T10:55:19.000Z thumbnail image

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.